Biological markers of exposure of foetus to alcohol during pregnancy

Pregnancy and Alcohol Consumption

Volumn , Issue , 2011, Pages 347-357

  Lamy, S ^a   Thibaut, F ^b  

^a Centre de prévention de Normandie Renouvance   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887937090     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (44)

1. Aalto M, Alho H, Halme JT et al. AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. Drug Alcohol Depend, 2009, 103:25-9.
2. Alvik A, Heyerdahl S, Haldorsen T et al. Alcohol use before and during pregnancy: a population-based study. Acta Obstet. Gynecol, Scand 2006, 85:1292-8.
3. Bakdash A, Burger P, Goecke TW et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal. Bioanal. Chem, 2010, 396:2469-77.
4. Bortolotti F, De Paoli G, Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, 2006, 841:96-109.
5. Coles CD, Platzman KA, Raskind-Hood CL et al. A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol. Clin. Exp. Res, 1997, 21(1):150-61.
6. Colvin L, Payne J, Kurinczuck JJ et al. Alcohol consumption during pregnancy in nonindigenous west Australian women. Alcohol. Clin. Exp. Res, 2007, 31:276-84.
7. Cook JD. Biochemical markers of alcohol use in pregnant women. Clin. Biochem, 2003, 36:9-19.
8. Day NL, Leech SL, Richardson GA et al. Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. Alcohol. Clin. Exp. Res, 2002, 99:283.
9. De Chazeron I, Llorca PM, Venditelli F et al. Is pregnancy the time to change alcohol consumption habits in France? Alcohol. Clin. Exp. Res, 2008, 32:868-73.
10. Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin. Invest. Med, 2007, 30:33-41.
11. Ewing T, John A. Detecting Alcoholism: The CAGE Questionnaire. JAMA, 1984, 252:1905-7.
12. Floyd DR, O'Connor MJ, Sokol RJ et al. Recognition and prevention of fetal alcohol syndrome. Obstet Gynecol, 2005, 106:1059-64.
13. Freeman WM, Salzberg AC, Gonzales SW et al. Classification of alcohol abuse by plasma protein biomarkers. Biol. Psychiatry, 2010, Mars 16, in press.
14. Gache P, Michaud P, Landry U et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol. Clin. Exp. Res, 2005, 29:2001-7.
15. Gareri J, Lynn H, Handley M et al. Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters. Ther. Drug Monit, 2008, 30:239-45.
16. Goldschmidt L, Richardson GA, Cornelius M et al. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol. Teratol. 2004, 26(4):521-32.
17. Hietala J, Koivisto H, Anttila P et al. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol, 2006, 41:528-33.
18. Kharbouche H, Sporkert F, Staub C et al. Ethyl glucuronide: a biomarker of alcohol consumption. Praxis, 2009, 98:1299-306.
19. Krenz S, Dieckmann S, Favrat B et al. French version of the Addiction Severity Index (5th edition): validity and reliability among swiss opiate-dependent patients. Eur. Addict. Res, 2004, 10:173-179.
20. Lamy S, Thibaut F. Psychoactive substance use during pregnancy: a review. Encéphale, 2010, 36(1):33-8.
21. Leech SL, Richardson GA, Goldschmidt L et al. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol. Teratol, 1999, 21(2):109-18.
22. Lozano J, Garcia-Algar O, Vall O et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther. Drug Monit, 2007, 29:711-34.
23. May PA, Gossage JP, Kalberg WO et al. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev. Disabil. Res. Rev, 2009, 15:176-92.
24. McLellan AT, Kushner H, Metzger D et al. The Fifth Edition of the Addiction Severity Index. J. Subst. Abuse Treat, 1992, 9:199-213.
25. McMillan H, Smaarani S, Walsh T et al. Smoking and alcohol in pregnancy. Survey in the immediate post-partum period. Ir. Med. J, 2006, 99:283.
26. Morini L, Groppi A, Marchei E et al. Population baseline of meconium ethyl glucuronide and ethyl sulfate concentrations in newborns of nondrinking women in 2 mediterranean cohorts. Ther. Drug Monit, 2010 Mar 23 in press.
27. Morini L, Marchei E, Vagnarelli F et al. Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study. Anal. Bioanal. Chem, 2010.
28. Morini L, Marchei E, Vagnarelli F et al. Ethyl glucuronide and ethyl sulfate in meconium and hair-potential biomarkers of intrauterine exposure to ethanol. Forensic. Sci. Int, 2010, 196:74-7.
29. Mulligan MK, Ponomarev I, Boehm SL et al. Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains. Genes Brain Behav, 2008, 7:677-89.
30. Niemelä O. Biomarkers in alcoholism. Clin. Chim. Acta, 2007, 377:39-49.
31. Ostrea EM Jr., Brielawski DM, Posecion NC et al. Combined analysis of prenatal (maternal hair and blood) and neonatal (infant hair, cord blood and meconium) matrices to detect fetal exposure to environmental pesticides. Environ. Res, 2009, 109:116-22.
32. Pichini S, Morini L, Marchei E et al. Ethylglucuronide and ethylsulfate in meconium to access gestational ethanol exposure: preliminary results in two Mediterranean cohorts. Can. J. Clin. Pharmacol, 2009, 16:370-5.
33. Pichini S, Puig C, Zuccaro P et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project". Forensic. Sci. Int, 2005, 153:59-65.
34. Pragst F, Yegles M. Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy? Ther. Drug Monit, 2008, 30:255-63.
35. Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol. Clin. Exp. Res, 2007, 31:185-99.
36. Rinck D, Freiling H, Freitag A et al. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol. Depend, 2007, 89:60-5.
37. Roebuck-Spencer TM, Mattson SN. Implicit strategy affects learning in children with heavy prenatal alcohol exposure. Alcohol. Clin. Exp. Res, 2004, 28:1424-31.
38. Rubinsky AD, Kivlahan DR, Volk RJ et al. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol. Depend, 2010, 108:29-36.
39. Schonfeld AM, Paley B, Frankel F et al. Executive functioning predicts social skills following prenatal alcohol exposure. Child Neuropsychol, 2006, 12:439-52.
40. Thompson BL, Levitt P, Stanwood GD. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nature Rev. Neurosci, 2009, 40:303-312.
41. Wurst FM, Metzger J. The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcohol. Clin. Exp. Res, 2002, 26:1114-9.
42. Wurst FM. Skipper GE. Weinmann W. Ethyl glucuronide--the direct ethanol metabolite on the threshold from science to routine use. Addiction, 2003, 98(S2):51-61.
43. Yegles M, Labarthe A, Auwärter V et al. Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic. Sci. Int, 2004, 145:167-73.
44. Zimmermann CM, Jackson GP. Gas chromatography tandem mass spectrometry for biomarkers of alcohol abuse in human hair. Ther. Drug Monit, 2010, 32:216-23.